成人Ross手术25年纵向临床结局
单中心前瞻性纳入1990至2014年310例成人Ross手术患者,中位随访15.1年、最长25年,无失访;10年与20年免于任何Ross相关再干预分别为92.9%和70.1%,总体生存分别为94.1%和83.6%。术前主动脉瓣反流、主动脉环扩大及同期升主动脉置换是自体移植物退变的独立危险因素。
要点
- 10年与20年免于Ross相关再干预率为92.9%和70.1%。
- 术前主动脉瓣反流、主动脉环扩大及同期升主动脉置换增加再干预风险。
- 需再干预者长期生存未显著变差,但整体生存低于年龄性别匹配人群。
核心结论
- Ross手术长期瓣膜结局与生存良好,且需再干预与否不影响长期生存。
- 与年龄性别匹配的普通人群相比,Ross术后患者生存显著更低(p<0.0001)。
研究设计与样本
- 所有患者纳入专用心脏手术登记,行完整术后临床检查与标准化经胸超声心动图,无失访,中位随访15.1年、最长25年。
主要发现
- 二叶式主动脉瓣227例(73.2%),最常见手术指征为主动脉瓣狭窄(225例,72.6%)。
- 免于任何Ross相关再干预率10年为92.9%、20年为70.1%。
- 自体肺动脉移植物退变独立危险因素:术前主动脉环扩大(HR 1.1;p=0.01)、术前主动脉瓣反流(HR 2.7;p=0.002)、同期升主动脉置换(HR 7.7;p=0.0003)。
- 住院死亡4例(1.3%),总体生存10年94.1%、20年83.6%。
- 需Ross相关再干预者与未需者的长期生存无显著差异(log-rank p=0.70)。
临床怎么用
- 对拟行Ross手术的成人应评估术前主动脉瓣反流、主动脉环大小及是否需同期升主动脉置换,以预判再干预风险。
- 术后长期随访应关注再干预风险与生存,即使无需再干预也需警惕生存低于匹配人群。
局限性
- 单中心回顾性设计(前瞻性登记),样本量310例,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Very few reports of long-term outcomes of patients who underwent the Ross procedure have been published. OBJECTIVES: The authors reviewed their 25-year experience with the Ross procedure with the aim of defining very-long-term survival and factors associated with Ross-related failure. METHODS: Between January 1990 and December 2014, the Ross procedure was performed in 310 adults (mean age 40.8 years) at a single institution. All patients were prospectively added to a dedicated cardiac surgery registry. Complete post-operative clinical examination and history were obtained, and transthoracic echocardiography was performed according to a standardized protocol. There was no loss to follow-up. Median follow-up was 15.1 years and up to 25 years. RESULTS: Bicuspid aortic valve was diagnosed in 227 patients (73.2%), and the most common indication for surgery was aortic stenosis (n = 225 [72.6%]). Freedom from any Ross-related reintervention was 92.9% and 70.1% at 10 and 20 years, respectively. Independent risk factors for pulmonary autograft degeneration were pre-operative large aortic annulus (hazard ratio: 1.1; p = 0.01), pre-operative aortic insufficiency (hazard ratio: 2.7; p = 0.002), and concomitant replacement of the ascending aorta (hazard ratio: 7.7; p = 0.0003). There were 4 hospital deaths (1.3%), and overall survival at 10 and 20 years was 94.1% and 83.6%, respectively. Long-term survival was not significantly different in patients who required Ross-related reintervention (log-rank p = 0.70). However, compared with the general population, survival was significantly lower in patients following the Ross procedure when matched on age and sex (p < 0.0001). CONCLUSIONS: The Ross procedure was associated with excellent long-term valvular outcomes and survival, regardless of the need for reintervention. Adults presenting with aortic insufficiency or a dilated aortic annulus or ascending aorta were at greater risk for reintervention. Unlike previous reports, long-term survival was lower in Ross patients compared with matched subjects.
引用
- Martin E, Mohammadi S, Jacques F, et al. Clinical Outcomes Following the Ross Procedure in Adults: A 25-Year Longitudinal Study. J Am Coll Cardiol. 2017. PMID: 28982503. doi:10.1016/j.jacc.2017.08.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。